Aquigen Bio Sciences

In the pharmaceutical world, precision and purity are everything. Every active pharmaceutical ingredient (API) must be rigorously analyzed — not just for its efficacy, but also for the presence of impurities that may arise during synthesis, storage, or degradation. One such impurity is   Ambrisentan Impurity E , an important compound in the quality control of Ambrisentan-based formulations. What is Ambrisentan Impurity E? Ambrisentan is a medication widely used to treat pulmonary arterial hypertension (PAH), working as an endothelin receptor antagonist to relax blood vessels and improve blood flow. Like many complex molecules, its synthesis can lead to the formation of structurally related impurities. Among these,  Impurity E  is particularly noteworthy due to its potential appearance as a by-product or degradation compound. Ambrisentan Impurity E is used as a  reference standard  in pharmaceutical analysis to ensure that any trace amounts present in the final d...

When it comes to pharmaceutical research and quality control, the need for highly characterized impurity standards cannot be overstated. Aquigen Bio, a leading name in the field of bioanalytical reference materials , offers a comprehensive range of Resmetirom impurity standards tailored to meet the stringent requirements of regulatory bodies and research laboratories. In this post, we spotlight five key products in our portfolio: Resmetirom Impurity 1 , Resmetirom Impurity 10 , Resmetirom Impurity 11 , Resmetirom Impurity 12 , and Resmetirom Impurity 13 . Why Resmetirom Impurities Matter Resmetirom is a selective thyroid hormone receptor-β (THR-β) agonist under investigation for treating nonalcoholic steatohepatitis (NASH). During the development, manufacturing, and quality assurance processes, the detection and quantification of Resmetirom impurities are critical to ensuring drug purity, efficacy, and patient safety. Explore Aquigen Bio’s Resmetirom Impurity Standards 1....

In pharmaceutical development and manufacturing, impurity profiling plays a crucial role in ensuring product safety, efficacy, and regulatory compliance. One such significant impurity is Bisoprolol EP Impurity A — a specified impurity listed in the European Pharmacopoeia (EP) monograph for Bisoprolol. What is Bisoprolol? Bisoprolol is a widely used beta-blocker, prescribed for hypertension, heart failure, and angina. Its cardioselective action makes it a preferred choice for reducing cardiovascular risk. However, as with all Active Pharmaceutical Ingredients (APIs), ensuring its purity is non-negotiable. During synthesis, storage, or degradation, Bisoprolol may form various impurities — including EP-specified ones such as: Bisoprolol EP Impurity A Bisoprolol Alcohol Impurity Bisoprolol Carboxylic Acid Impurity Bisoprolol EP Impurity D Bisoprolol EP Impurity C Spotlight on Bisoprolol EP Impurity A Bisoprolol EP Impurity A is a structurally related compound that ...

N-Nitroso Mirabegron has recently drawn increased attention due to rising regulatory focus on nitrosamine impurities in pharmaceuticals. As a byproduct of the synthesis of Mirabegron—a widely used drug for treating overactive bladder—this impurity must be carefully monitored and controlled to ensure patient safety and regulatory compliance. What is N-Nitroso Mirabegron? N-Nitroso Mirabegron is a nitrosamine derivative formed during the manufacturing of Mirabegron. Nitrosamines, in general, are known for their potential carcinogenic properties, which is why even trace amounts can raise safety concerns. As a result, global regulatory bodies now mandate strict limits on the presence of these impurities in medicinal products. You can learn more about this N-Nitroso Mirabegron Why Are Nitrosamine Impurities Concerning? Nitrosamines are formed under specific conditions—typically involving secondary or tertiary amines reacting with nitrosating agents. While not all nitrosamines are harm...

In recent years, the pharmaceutical industry has heightened its focus on nitrosamine impurities—compounds that have raised significant health concerns due to their potential carcinogenicity. Among these, N-Nitroso Olanzapine and its related derivatives have become particularly important in the context of olanzapine-based medications, which are widely prescribed for conditions such as schizophrenia and bipolar disorder. What is N-Nitroso Olanzapine? N-Nitroso Olanzapine is a nitrosamine impurity that may be present in trace amounts during the manufacturing or storage of olanzapine. Given the stringent safety regulations from global health authorities, detecting and controlling such impurities is essential to maintain drug quality and patient safety. AquigenBio addresses this need by providing high-purity impurity standards, crucial for analytical testing and method development. Their N-Nitroso Olanzapine EP Impurity D is designed for use in impurity profiling, stability studies, a...

Carprofen is a widely used non-steroidal anti-inflammatory drug (NSAID), especially common in veterinary medicine for the treatment of inflammation and pain in dogs. Like any pharmaceutical compound, Carprofen must meet strict quality standards during manufacturing. One key aspect of ensuring this quality is the identification and control of impurities—one of which is Carprofen Impurity 2 . What is Carprofen Impurity 2? Carprofen Impurity 2 is one of the known and characterized impurities that can be found during the synthesis or degradation of Carprofen. The exact chemical structure and identity may vary slightly depending on the synthetic route used, but it is typically a structurally related compound that arises as a by-product or during shelf-life degradation. Why is it Important? Pharmaceutical impurities , even in trace amounts, can impact the efficacy, safety, and stability of the final drug product. Regulatory bodies like the US FDA , EMA , and ICH (International Council ...

In the pharmaceutical world, ensuring drug safety isn't just about the active ingredients—it's also about the impurities that might form during manufacturing or storage. One such impurity that has garnered attention is N-Nitroso Dorzolamide . What is N-Nitroso Dorzolamide? N-Nitroso Dorzolamide is a nitrosamine impurity that can be associated with Dorzolamide , a medication commonly used in eye drops to treat elevated intraocular pressure in conditions like glaucoma. While Dorzolamide itself is safe and effective, the presence of nitrosamine derivatives like N-Nitroso Dorzolamide raises safety concerns. Why Are Nitrosamines a Concern? Nitrosamines have been under scrutiny in the pharmaceutical industry because of their potential carcinogenic properties. Even trace amounts in medications have prompted regulatory bodies like the FDA and EMA to establish strict limits. The formation of N-Nitroso Dorzolamide can happen due to chemical reactions during the synthesis or degradatio...

Carprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID), primarily prescribed for pain and inflammation management in veterinary medicine. While its therapeutic benefits are well-documented, the presence of impurities in pharmaceutical formulations can impact drug safety and efficacy. One such impurity is Carprofen Impurity 2, an essential consideration in quality control and regulatory compliance. What is Carprofen Impurity 2? Carprofen Impurity 2 is a byproduct that may arise during the synthesis, storage, or degradation of Carprofen. The presence of such impurities in pharmaceutical compounds is closely monitored to ensure compliance with safety standards and regulatory guidelines. Impurities in drugs are categorized based on their origin—whether they result from raw materials, intermediates, or degradation processes. Significance in Pharmaceutical Quality Control The presence of Carprofen Impurity 2 must be evaluated to prevent potential toxicity, altered pharma...